Evidence map›Paper›PMID 40406394›Full record

ArticleMaternal-fetal medicine (Wolters Kluwer Health, Inc.)2023

Recommendations for the Diagnosis and Treatment of Maternal SARS-CoV-2 Infection.

Dunjin Chen, Yue Dai, Xinghui Liu, Hongbo Qi, Chen Wang, Lan Wang, Yuan Wei, Xiaochao Xu, Chuan Zhang, Lingli Zhang and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Maternal-fetal medicine (Wolters Kluwer Health, Inc.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Dunjin ChenDepartment of Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China.
Yue DaiNational Health Commission of the People's Republic of China, Beijing 100044, China.
Xinghui LiuDepartment of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
Hongbo QiAdministration Office, Chongqing Health Center for Women and Children, Chongqing 401120, China.
Chen WangDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing Key Laboratory of Maternal Fetal Medicine of Gestational Diabetes Mellitus, Beijing 100034, China.
Lan WangAdministration Office, Chongqing Health Center for Women and Children, Chongqing 401120, China.
Yuan WeiDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100083, China.
Xiaochao XuNational Health Commission of the People's Republic of China, Beijing 100044, China.
Chuan ZhangDepartment of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
Lingli ZhangDepartment of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
Yuquan ZhangDepartment of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong 226001, China.
Ruihua ZhaoDepartment of Obstetrics and Gynecology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Yangyu ZhaoDepartment of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100083, China.
Borong ZhouDepartment of Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China.
Ai-Ling WangNational Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, Beijing 100081, China.
Huixia YangDepartment of Obstetrics and Gynecology, Peking University First Hospital, Beijing Key Laboratory of Maternal Fetal Medicine of Gestational Diabetes Mellitus, Beijing 100034, China.
Li SongNational Health Commission of the People's Republic of China, Beijing 100044, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread worldwide and threatened human's health. With the passing of time, the epidemiology of coronavirus disease 2019 evolves and the knowledge of SARS-CoV-2 infection accumulates. To further improve the scientific and standardized diagnosis and treatment of maternal SARS-CoV-2 infection in China, the Chinese Society of Perinatal Medicine of Chinese Medical Association commissioned leading experts to develop the Recommendations for the Diagnosis and Treatment of Maternal SARS-CoV-2 Infection under the guidance of the Maternal and Child Health Department of the National Health Commission. This recommendations includes the epidemiology, diagnosis, management, maternal care, medication treatment, care of birth and newborns, and psychological support associated with maternal SARS-CoV-2 infection. It is hoped that the recommendations will effectively help the clinical management of maternal SARS-CoV-2 infection.

Indexed as

COVID-19DiagnosisNewbornsPregnancyRecommendationSARS-CoV-2Treatment

Identifiers

PMID40406394
PMCPMC12094392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.